JPS52113954A - Local pharmaceutical agent containing clindamycine - Google Patents

Local pharmaceutical agent containing clindamycine

Info

Publication number
JPS52113954A
JPS52113954A JP2936277A JP2936277A JPS52113954A JP S52113954 A JPS52113954 A JP S52113954A JP 2936277 A JP2936277 A JP 2936277A JP 2936277 A JP2936277 A JP 2936277A JP S52113954 A JPS52113954 A JP S52113954A
Authority
JP
Japan
Prior art keywords
clindamycine
agent containing
pharmaceutical agent
local pharmaceutical
local
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2936277A
Other languages
English (en)
Inventor
Emorii Eiyaa Donarudo
Arubin Shiyureegeru Kaaru
Reonaado Furin Goodon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/668,389 external-priority patent/US4018918A/en
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of JPS52113954A publication Critical patent/JPS52113954A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2936277A 1976-03-19 1977-03-18 Local pharmaceutical agent containing clindamycine Pending JPS52113954A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/668,389 US4018918A (en) 1975-05-20 1976-03-19 Topical clindamycin preparations

Publications (1)

Publication Number Publication Date
JPS52113954A true JPS52113954A (en) 1977-09-24

Family

ID=24682131

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2936277A Pending JPS52113954A (en) 1976-03-19 1977-03-18 Local pharmaceutical agent containing clindamycine

Country Status (7)

Country Link
JP (1) JPS52113954A (ja)
BE (1) BE852649R (ja)
DE (1) DE2710880A1 (ja)
FR (1) FR2344288A2 (ja)
GB (1) GB1527061A (ja)
NL (1) NL7702822A (ja)
ZA (1) ZA77943B (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04169529A (ja) * 1990-10-30 1992-06-17 Nippon Soda Co Ltd 家蓄の***炎を予防する方法
JPH05501115A (ja) * 1990-03-27 1993-03-04 シェリング・コーポレーション 9α―ヒドロキシ ステロイドの脱水法

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214318B1 (en) 1997-10-02 2001-04-10 Oms Holdings Llc Aerosol ointment compositions for topical use
EP1019024B1 (en) * 1997-10-02 2004-01-07 OMS Holdings, LLC Aerosol ointment compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1403962A (en) * 1972-03-09 1975-08-28 Upjohn Co Anti-inflammatory pregnane derivative

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05501115A (ja) * 1990-03-27 1993-03-04 シェリング・コーポレーション 9α―ヒドロキシ ステロイドの脱水法
JPH04169529A (ja) * 1990-10-30 1992-06-17 Nippon Soda Co Ltd 家蓄の***炎を予防する方法

Also Published As

Publication number Publication date
DE2710880A1 (de) 1977-09-29
BE852649R (fr) 1977-09-19
FR2344288B2 (ja) 1980-04-04
ZA77943B (en) 1977-12-28
NL7702822A (nl) 1977-09-21
GB1527061A (en) 1978-10-04
FR2344288A2 (fr) 1977-10-14

Similar Documents

Publication Publication Date Title
JPS52145525A (en) Local antiiinflammation agent
JPS52143218A (en) Pharmaceutical composition
JPS52134027A (en) Antiitumor agent
JPS52113976A (en) Pharmaceutical composition
JPS5362838A (en) Pharmaceutical composition
JPS52102432A (en) Pharmaceutical composition containing pyretrinoid
JPS5372814A (en) Pharmaceutical composition
JPS5325525A (en) Radiooopaque agent
JPS5470433A (en) Antiiulcer agent
JPS5299230A (en) Antiitumor agent
JPS52118497A (en) Antiiallergy agent
AU3152677A (en) Pharmaceutical composition
JPS5369822A (en) Pharmaceutical agent
JPS5297933A (en) Antiihypertensive agent
JPS5356634A (en) Pharmaceutical composition
AU2649977A (en) Pharmaceutical composition
JPS535195A (en) Antiibacterial agent
JPS5335084A (en) Airzol size agent
JPS52117436A (en) Antiicoccidium agent
SU725543A3 (en) Insecticidic agent
JPS5386040A (en) Antiicoagulating agent
JPS52113954A (en) Local pharmaceutical agent containing clindamycine
JPS5335085A (en) Airzol size agent
JPS5372828A (en) Antiicancer agent
JPS5377055A (en) Antiilinoovirus agent